Berylson Capital Partners’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,196,200
Closed -$20.1M 60
2020
Q4
$20.1M Buy
+1,196,200
New +$13.3M 3.43% 6

Other funds holding CLOV

Berylson Capital Partners's CLOV Position: Q1 2021 in Review

Berylson Capital Partners sold out of Clover Health Investments (CLOV) in Q1 2021, closing a stake of 1,196,200 shares — an estimated $20.1M sold.

Berylson Capital Partners first reported a position in CLOV in Q4 2020 and held it in 1 quarter. The position peaked at $20.1M in Q4 2020. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2021.

  • Berylson Capital Partners reported no remaining Clover Health Investments position as of Q1 2021 after selling out during the quarter.
  • Berylson Capital Partners sold 1,196,200 Clover Health Investments shares in Q1 2021, an estimated $20.1M.
  • Berylson Capital Partners first reported a position in Clover Health Investments in Q4 2020 and held it in 1 quarter.
  • Berylson Capital Partners's Clover Health Investments position peaked at $20.1M in Q4 2020.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2021.

Based on Berylson Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.